Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Charles River Laboratories International, Inc. before investing.

In this article, we go over a few key elements for understanding Charles River Laboratories International, Inc.’s stock price such as:

• Charles River Laboratories International, Inc.’s current stock price and volume
• Why Charles River Laboratories International, Inc.’s stock price changed recently
• Upgrades and downgrades for CRL from analysts
• CRL’s stock price momentum as measured by its relative strength

About Charles River Laboratories International, Inc. (CRL)

Before we jump into Charles River Laboratories International, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children’s Hospital Los Angeles across its contract development and manufacturing organization. Additionally, it has a strategic alliance with Francis Crick Institute (Crick), Inc. for the development of Antibody-Drug Conjugate (ADC) drug discovery and development. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Want to learn more about Charles River Laboratories International, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Charles River Laboratories International, Inc..

Charles River Laboratories International, Inc.’s Stock Price as of Market Close

As of June 18, 2026, 4:00 PM, CST, Charles River Laboratories International, Inc.’s stock price was $185.000.

Charles River Laboratories International, Inc. is up 1.46% from its previous closing price of $182.340.

During the last market session, Charles River Laboratories International, Inc.’s stock traded between $181.960 and $186.180. Currently, there are approximately 48.95 million shares outstanding for Charles River Laboratories International, Inc..

Charles River Laboratories International, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Charles River Laboratories International, Inc. Stock Price History

Charles River Laboratories International, Inc.’s (CRL) price is currently up 2.37% so far this month.

During the month of June, Charles River Laboratories International, Inc.’s stock price has reached a high of $193.810 and a low of $169.460.

Over the last year, Charles River Laboratories International, Inc. has hit prices as high as $228.880 and as low as $144.260. Year to date, Charles River Laboratories International, Inc.’s stock is down 7.26%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Charles River Laboratories International, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of June 18, 2026, there was 1 analyst who downgraded Charles River Laboratories International, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Charles River Laboratories International, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Charles River Laboratories International, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Charles River Laboratories International, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Charles River Laboratories International, Inc. (CRL) by visiting AAII Stock Evaluator.

Relative Price Strength of Charles River Laboratories International, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 18, 2026, Charles River Laboratories International, Inc. has a weighted four-quarter relative price strength of 2.15%, which translates to a Momentum Score of 65 and is considered to be Strong.

Want to learn more about how Charles River Laboratories International, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Charles River Laboratories International, Inc. Stock Price: Bottom Line

As of June 18, 2026, Charles River Laboratories International, Inc.’s stock price is $185.000, which is up 1.46% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Charles River Laboratories International, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.